To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

No advantage of dexamethasone injection for lateral elbow pain in 6 month period

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Author Verified
Ace Report Cover
April 2013

No advantage of dexamethasone injection for lateral elbow pain in 6 month period

Vol: 2| Issue: 3| Number:9| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Injection of Dexamethasone Versus Placebo for Lateral Elbow Pain: A Prospective, Double-Blind, Randomized Clinical Trial

J Hand Surg Am. 2008 Jul-Aug;33(6):909-19

Contributing Authors:
Anneluuk Lindenhovius Marjolijn Henket Brendan P Gilligan Santiago Lozano-Calderon Jesse B Jupiter David Ring

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

64 patients with lateral elbow pain were randomly assigned to receive dexamethasone or a placebo injection, in order to evaluate the efficacy of dexamethasone. Assessments over a 6 month period indicated that corticosteroid injections for lateral elbow pain did not affect the clinical course or outcomes. It was also determined that the perceived disability associated with lateral elbow pain that a...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue